Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Funko Pop! Plans to Dump $30M of Collectibles to Lower Inventory Costs
Collectables brand Funko Pop! is struggling to off load inventory and now plans to eliminate approximately $30 million to $36 million dollars worth of product.
TikTok's GirlBossTown Robyn DelMonte Talks Building Successful Social Media Brands
Public relations expert and successful TikToker Robyn DelMonte joined Cheddar News to provide some insight into effective strategies for building a brand through social media.
Racial Divide in American Homeownership Widest in a Decade
More Americans own homes today, but the gap in homeownership between Black and white people is at its widest in 10 years.
Today Explained: Homeownership Gap Between Black and White Americans at Widest In A Decade
Today Explained: Homeownership Gap Between Black and White Americans at Widest In A Decade
Dow Shows First Weekly Gain Since Late January
Danielle DiMartino Booth, CEO and chief strategist of Quill Intelligence, joined Cheddar News to discuss the market that is still digesting comments from the Federal Reserve about its monetary policy.
Study Shows ATM Use Decline as Consumers Opt for Digital Payment Methods
A study by research company Euromonitor International found that the number of available banking machines in the U.S. has dropped by more than 18,000 since 2019.
Apple Shifts iPhone Production To India With New Factory
Apple is building a new iPhone factory in India as it shifts some production there from China.
Meta Slashes Prices For VR Headsets
Meta slashed prices of its Quest virtual reality headsets.
The Week's Top Stories: Target Falls, Ford Speeds Up and the Rise of AI
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
